- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 455/03 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberineAlkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberineAlkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
Patent holdings for IPC class C07D 455/03
Total number of patents in this class: 150
10-year publication summary
12
|
8
|
9
|
6
|
7
|
10
|
12
|
12
|
9
|
12
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Shenzhen HighTide Biopharmaceutical, Ltd. | 57 |
13 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 823 |
9 |
Nanjing Shijiang Medicine Technology Co., Ltd | 26 |
7 |
Institute of Materia Medica, Chinese Academy of Medical Sciences | 177 |
5 |
SpecGx LLC | 183 |
5 |
Shanghai Shijiang Biotechnology Co., Ltd | 8 |
5 |
CVI Pharmaceuticals Limited | 10 |
4 |
Merck Patent GmbH | 5831 |
3 |
China Pharmaceutical University | 299 |
3 |
Topharman Shanghai Co., Ltd. | 54 |
3 |
Centre National de La Recherche Scientifique | 10418 |
2 |
FUJIFILM Corporation | 29367 |
2 |
Beijing Tide Pharmaceutical Co. Ltd. | 92 |
2 |
Changzhou Deze Medical Science Co., Ltd | 3 |
2 |
Dalian Institute of Chemical Physics, Chinese Academy of Sciences | 674 |
2 |
Harbin Medisan Pharmaceutical Co., Ltd. | 16 |
2 |
LMS Co., Ltd. | 241 |
2 |
Mallinckrodt LLC | 132 |
2 |
Tongji University | 507 |
2 |
Universite Claude Bernard Lyon 1 | 1023 |
2 |
Other owners | 73 |